Back to top

Buy Rating Reiterated on Sobi as NASP Delay Seen as Timing Issue; SEK 550 Price Target Maintained

Mitchell Kapoor, an analyst from H.C. Wainwright, reiterated the Buy rating on Swedish Orphan Biovitrum AB. The associated price target remains the...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Swedish Orphan Biovitrum (BIOVF)